Leong Kin Fon, Sato Reiko, Oh Glenda Guek Khim, Surana Uttam, Pramono Zacharias Aloysius Dwi
Department of Pediatrics, Institute of Pediatric, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur 50586, Malaysia.
Department of Research, National Skin Center, Singapore 308205, Singapore.
Indian J Dermatol. 2019 Sep-Oct;64(5):400-403. doi: 10.4103/ijd.IJD_44_18.
Blau syndrome (BS) is a very rare autosomal dominant juvenile inflammatory disorder caused by mutation in nucleotide-binding oligomerization domain containing 2 . Usually, dermatitis is the first symptom that appears in the 1 year of life. About 220 BS cases with confirmed mutation have been reported. However, the rarity and lack of awareness of the disease, especially in the regions where genetic tests are very limited, often result in late diagnosis and misdiagnosis. Here, we report a BS case from Malaysia, which may be the first report from southeast Asia. PCR and DNA sequencing of peripheral blood mononuclear cells were performed to screen the entire coding region of gene. A heterozygous c.1000C>T transition in exon 4, p. R334W, of the gene was identified in the patient. This report further reaffirms the ubiquitousness of the disease and recurrency of p. R334W mutation.
布劳综合征(BS)是一种非常罕见的常染色体显性遗传性青少年炎症性疾病,由含核苷酸结合寡聚化结构域2的基因突变引起。通常,皮炎是出生后1年内出现的首个症状。已报道约220例确诊突变的布劳综合征病例。然而,该疾病的罕见性以及对其认识不足,尤其是在基因检测非常有限的地区,常常导致诊断延迟和误诊。在此,我们报告一例来自马来西亚的布劳综合征病例,这可能是东南亚地区的首例报告。我们对外周血单个核细胞进行了聚合酶链反应(PCR)和DNA测序,以筛查该基因的整个编码区。在患者中鉴定出该基因第4外显子的杂合c.1000C>T转换,即p.R334W。本报告进一步证实了该疾病的普遍性以及p.R334W突变的反复出现。